Independent Research GmbH set a €32.00 ($37.21) target price on Rhön-Klinikum Aktiengesellschaft (ETR:RHK) in a report released on Monday. The firm currently has a neutral rating on the stock.

A number of other brokerages have also weighed in on RHK. Warburg Research set a €26.30 ($30.58) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a neutral rating in a research note on Tuesday, November 7th. Berenberg Bank set a €29.15 ($33.90) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a neutral rating in a research note on Monday, November 6th. Commerzbank Ag set a €25.00 ($29.07) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a neutral rating in a research note on Friday. Baader Bank set a €24.00 ($27.91) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a neutral rating in a research note on Friday. Finally, S&P Global set a €25.00 ($29.07) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a sell rating in a research note on Friday. Four investment analysts have rated the stock with a sell rating and six have issued a hold rating to the stock. The company presently has a consensus rating of Hold and an average target price of €25.05 ($29.13).

Shares of Rhön-Klinikum Aktiengesellschaft (ETR:RHK) traded down €0.18 ($0.21) during midday trading on Monday, reaching €30.02 ($34.91). The company’s stock had a trading volume of 85,284 shares, compared to its average volume of 71,494. Rhön-Klinikum Aktiengesellschaft has a 12-month low of €22.66 ($26.35) and a 12-month high of €30.65 ($35.64).

TRADEMARK VIOLATION NOTICE: “Rhön-Klinikum Aktiengesellschaft (RHK) Given a €32.00 Price Target at Independent Research GmbH” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.watchlistnews.com/rhon-klinikum-aktiengesellschaft-rhk-given-a-32-00-price-target-at-independent-research-gmbh/1702889.html.

About Rhön-Klinikum Aktiengesellschaft

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhön-Klinikum Aktiengesellschaft (ETR:RHK)

Receive News & Ratings for Rhön-Klinikum Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhön-Klinikum Aktiengesellschaft and related companies with Analyst Ratings Network's FREE daily email newsletter.